Your search for omalizumab returned 31 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for omalizumab returned 31 results

Sort Results:

Relevant Recent

Anaphylaxis warning for Xolair

The FDA has requested that Genentech add a boxed warning to its asthma drug Xolair (omalizumab). The boxed warning emphasizes that patients taking Xolair may develop anaphylaxis after any dose, even if there was no reaction to the first dose. Anaphylaxis may be delayed up to 24 hours after the dose is given. Patients should…

Asthma drug relieves hives symptoms

Omalizumab may elicit more of a response in patients with chronic idiopathic urticaria than do H1-antihistamines.
Next post in Asthma Information Center